Difference in values between reanalysed and ISR samples [Bioanalytics]

posted by Ken Peh – Malaysia, 2013-03-16 15:40 (4457 d 22:06 ago) – Posting: # 10206
Views: 4,007

Dear Cakhatri,

According to EMEA Guideline on Bioanalytical Method Validation (2011), the concentration obtained for the initial analysis and reanalysis should be within 20% of their mean for at least 67% of the repeats. Large differences between results may indicate analytical issues and should be investigated.

If I interpret the guideline correctly, as long as you have more than 67% of the repeats within 20% of their means, you are safe.

What do you mean when you mentioned "ISR passed with more than 95% acceptance criteria" ?

I have no experience dealing with FDA on ISR. Any guideline by FDA on this matter ??

Regards,
Ken

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,682 registered users;
132 visitors (0 registered, 132 guests [including 21 identified bots]).
Forum time: 14:46 CEST (Europe/Vienna)

If you want to get people to believe
something really, really stupid,
just stick a number on it.    Charles Seife

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5